Beneficio de la nefrectomía en el tratamiento del carcinoma de células renales metastásico

Patients treated with NEP associated to systemic treatment and with an intermediate/low risk in the Motzer classification had a better PFS and OS. The OS also improves in patients treated with mTOR in second line, and Karnofsky performance status > 80%in the univariate study, but not in the multivariable one.